This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Pain, Burning, Pain, Crushing, Pain, Migratory, Pain, Radiating or Pain, Splitting
and you are
between 18 and 99
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to compare the safety and effectiveness of JNJ-42160443 with placebo in the treatment of chronic, moderate to severe cancer-related pain in terminally ill patients with a diagnosis of active cancer.

Provided treatments

  • Drug: JNJ-42160443
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT00929188. The sponsor of the trial is Janssen Research & Development, LLC and it is looking for 100 volunteers for the current phase.
Official trial title:
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 as Adjunctive Therapy in Subjects With Cancer-Related Pain, Followed by an Open-Label Extension Phase